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T cell uropods are enriched in specific proteins including adhesion receptors such as P-
selectin glycoprotein ligand-1 (PSGL-1), lipid raft-associated proteins such as flotillins and
ezrin/radixin/moesin (ERM) proteins which associate with cholesterol-rich raft domains and
anchor adhesion receptors to the actin cytoskeleton. Using dominant mutants and siRNA
technology we have tested the interactions among these proteins and their role in shaping
theT cell uropod. Expression of wild type (WT) ezrin-EGFP failed to affect the morphology of
humanT cells or chemokine-induced uropod recruitment of PSGL-1 and flotillin-1 and -2. In
contrast, expression of constitutively active T567D ezrin-EGFP induced a motile, polarized
phenotype in some of the transfected T cells, even in the absence of chemokine. These
cells featured F-actin-rich ruffles in the front and uropod enrichment of PSGL-1 and flotillins.
T567D ezrin-EGFP was itself strongly enriched in the rear of the polarizedT cells. Uropod for-
mation induced byT567D ezrin-EGFP was actin-dependent as it was attenuated by inhibition
of Rho-kinase or myosin II, and abolished by disruption of actin filaments. While expres-
sion of constitutively active ezrin enhanced cell polarity, expression of a dominant-negative
deletion mutant of ezrin, 1–310 ezrin-EGFP, markedly reduced uropod formation induced
by the chemokine SDF-1,T cell front-tail polarity, and capping of PSGL-1 and flotillins.Trans-
fection of T cells with WT or T567D ezrin did not affect chemokine-mediated chemotaxis
whereas 1–310 ezrin significantly impaired spontaneous 2D migration and chemotaxis.
siRNA-mediated downregulation of flotillins in murine T cells attenuated moesin capping
and uropod formation, indicating that ERM proteins and flotillins cooperate in uropod forma-
tion. In summary, our results indicate that activated ERM proteins function together with
flotillins to promote efficient chemotaxis ofT cells by structuring the uropod of migratingT
cells.
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INTRODUCTION
T-lymphocytes are highly motile cells that are crucial for rapid
recognition of foreign antigens and destruction of virally infected
cells or tumor cells. T cell motility is indispensable for fulfilment of
these functions. T cell polarization and directional migration are
complex processes that are not well understood. Upon stimulation
with chemokines, T-lymphocytes rapidly develop a contracted tail
(uropod) and an F-actin-rich front with protrusions. T cell front-
tail polarity is a prerequisite for efficient crawling. Polarization
and migration require a functional cytoskeleton, reversible actin
polymerization in the front, and myosin-dependent contractility
in the rear (Krummel and Macara, 2006; Ley et al., 2007; Friedl
and Weigelin, 2008). We are interested in unraveling mechanisms
involved in development of self-organizing front-tail polarity in
leukocytes.
Development of front-tail polarity in leukocytes requires seg-
regation and activation of specific signaling and cytoskeletal
molecules in the retracting rear and protrusive leading edge
of the cells. This process is independent of an external gradi-
ent of chemoattractant. Localized positive feedback loops and
inhibitory effects of front signaling pathways on rear signaling
and vice versa are thought to reinforce this biochemical and
structural cell polarization (Bagorda and Parent, 2008). Specific
proteins, including adhesion receptors, cytoskeletal proteins, and
membrane-microdomain scaffolding proteins such as flotillin-1
and -2, have been shown to segregate to the uropod of polarizing T-
lymphocytes (Sánchez-Madrid and Serrador, 2009; Affentranger
et al., 2011; Baumann et al., 2012). Localized Rho activation in
the rear results in uropod contraction and suppresses forma-
tion of protrusions; localized Rac activation in the front induces
formation of F-actin-rich protrusions. The T cell uropod has
been implicated in migration through constricted spaces and may
mediate recruitment of other cells (Serrador et al., 1997; Sánchez-
Madrid and Serrador, 2009; Soriano et al., 2011). We previously
have shown that flotillins are involved in T cell uropod formation
(Affentranger et al., 2011). In this work, we focus on the role of the
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F-actin-plasma membrane linkers ezrin/radixin/moesin (ERM)
in T cell uropod formation, and ask how this relates to that of
flotillins.
The closely related ERM proteins are ubiquitously expressed in
mammalian tissues. They occur in a dormant and an activated
form. Interaction with phosphatidylinositol 4,5-bisphosphate
(PIP-2) induces conformational changes in ERM proteins, which
subsequently allow C-terminal phosphorylation for stable acti-
vation. PIP-2 is required in T cells for continuous membrane
association and maintenance of the phosphorylated form of the
ERM proteins (Barret et al., 2000; Fievet et al., 2004; Hao et al.,
2009; Ben-Aissa et al., 2012). Activated ERM proteins bind to
F-actin with their C-terminus and to cytoplasmic tails of trans-
membrane proteins or protein adaptors with their N-terminal
FERM domain, thus connecting the cortical F-actin network to
the plasma membrane (Niggli and Rossy, 2008; Neisch and Fehon,
2011). Human T-lymphocytes express mainly moesin and ezrin.
In resting T cells, ERM proteins are strongly phosphorylated and
associated with the plasma membrane. Chemokine activation of
human T cells is accompanied by a transient partial dephos-
phorylation of ERM proteins and partial dissociation from the
plasma membrane (Brown et al., 2003; Hao et al., 2009). Later,
C-terminally phosphorylated ERM (P-ERM) proteins accumulate
in the uropod of chemokine-stimulated T cells, recruiting trans-
membrane adhesion receptors such as PSGL-1 to this site and
colocalizing with the lipid raft-associated flotillins (Lee et al., 2004;
Sánchez-Madrid and Serrador, 2009; Affentranger et al., 2011).
Conflicting data have been published on the role of ERM
proteins in chemokine-induced polarization and migration of T-
lymphocytes. In studies with a murine T lymphoma cell line and
with naïve human T cells, overexpression of the phosphomimetic,
constitutively active mutant ezrin T567D [but not of wild type
(WT) ezrin] has been reported to increase the size of the uropod
and enhance chemokine-induced chemotaxis (Lee et al., 2004; Li
et al., 2007). In human T-lymphoblasts, transfection with con-
stitutively active moesin reverted inhibition of polarization and
motility mediated by constitutively active Rac (Cernuda-Morollon
et al., 2010). Conversely, transfection with the N-terminal part
of ezrin (aa 1–366) partially reduced the fraction of T cells with
uropods (Lee et al., 2004). The latter deletion mutant is thought
to act as a dominant-negative mutant, by competing with endoge-
nous ERM proteins for binding sites on receptors, thus uncoupling
the receptors from the cortical actin network (Martin et al., 1995;
Faure et al., 2004). Lee et al. (2004) propose that ERM proteins
accumulate at the site of the future uropod and locally activate
Rho, resulting in formation of a contracted uropod. In line with
these findings,naïve T cells derived from mice lacking moesin show
reduced in vitro chemotaxis to CXCL12 and CCL21 (Hirata et al.,
2012). Moreover murine T-lymphoblasts lacking ezrin and with
strongly reduced moesin expression chemotax less efficiently in
response to CCL19 than WT cells through 3µm pores in transwell
assays (Chen et al., 2013).
In contrast to these data, Brown et al. (2003) observed that
expression of constitutively active moesin T558D in ex vivo
human T cells delayed SDF-1-induced cell polarization and inhib-
ited resorption of microvilli. Liu et al. (2012) reported that
T-lymphoblasts isolated from mice expressing phosphomimetic
ezrin T567E specifically in T cells show attenuated in vitro migra-
tion and chemotaxis and in vivo homing and transmigration, as
well as reduced lamellipod extension, as compared to cells over-
expressing WT ezrin. The attenuation of protrusion in these cells
was attributed to increased membrane tension due to increased
actin-membrane linkage via T567E ezrin.
We have now attempted to clarify the role of ERM proteins in T
cell polarization, uropod scaffolding, and migration using expres-
sion of WT, constitutively active and dominant-negative ezrin
proteins. Our data clearly support a positive role for ERM pro-
teins in T cell polarization and migration. Our results also suggest
that ERM proteins and flotillins mutually promote their uropod
capping and thus cooperate in uropod formation.
MATERIALS AND METHODS
MATERIALS AND SUPPLIERS
Stromal cell-derived factor 1 (SDF-1=CXCL12): Peprotech.
Latrunculin A: Alexis Biochemicals. Blebbistatin: Enzo Life Sci-
ences. Y-27632: Calbiochem. Bovine serum albumin (BSA): Serva.
Lysolecithin (l-α-lysophosphatidylcholine): Sigma. Hoechst
33342: Sigma-Aldrich. Gey’s solution contained 138 mM NaCl,
6 mM KCl, 100µM EGTA, 1 mM Na2HPO4, 5 mM NaHCO3,
5.5 mM glucose, and 20 mM HEPES (pH 7.4).
ANTIBODIES
A polyclonal anti-CD3 antibody (Cat. No. RM-9107) was obtained
from NeoMarkers. Polyclonal antibodies directed against moesin
(Cat. No. 3150), ERM (Cat. No. 3142), and phospho ezrin
(Thr567)/radixin (Thr564)/moesin (Thr558) (Cat. No. 3141) were
from Cell Signaling Technology. Polyclonal antibodies raised in
rabbits against full-length human recombinant ezrin and against
the recombinant N-terminal domain of ezrin (Andreoli et al.,
1994) were kindly provided by P. Mangeat (Université Mont-
pellier II, France). A polyclonal antibody specifically recogniz-
ing β-cytoplasmic actin was kindly provided by C. Chaponnier
(Dugina et al., 2009). Monoclonal murine antibodies directed
against flotillin-2 (Cat. No. E35820) and PSGL-1 (Cat. No. 556053)
were obtained from Transduction Laboratories/BD Pharmin-
gen, Germany. The Alexa 488-conjugated goat-anti-rabbit (Cat.
No. A11008) and Alexa-568-conjugated goat anti-mouse IgG
antibodies (Cat. No. A11001) were from Molecular Probes.
CONSTRUCTS
Constructs encoding WT full-length human ezrin tagged at its
C-terminus with EGFP (WT ezrin) and a dominant-negative dele-
tion mutant of human ezrin (aa 1–310) C-terminally tagged with
EGFP were kindly provided by Lamb et al. (1997). Ezrin cloned
into the plasmid pEGFP-N1 was used as a PCR template to gener-
ate the constitutively active mutant ezrin T567D. The single-point
mutation was inserted by PCR and the products were cloned
into the vector pEGFP-N1 (ClonTech Laboratories) (primer for
the mutation: ggacaagtacaaggacctgcggcagatcc). Constructs encod-
ing flotillin-1 and -2 C-terminally tagged with mCherry were
generated as described previously (Rossy et al., 2009).
ISOLATION OF T-LYMPHOCYTES
Human T cells were isolated from buffy coats using the Pan T Cell
Isolation Kit II (Miltenyi Biotec) and separation on LD columns
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(Miltenyi Biotec) according to the manufacturers instructions.
Briefly, mononuclear cells obtained from buffy coats as described
(Affentranger et al., 2011) were incubated with a cocktail of biotin-
conjugated antibodies against CD14, CD16, CD19, CD36, CD56,
CD123, and CD235a (glycophorin A). Cells binding these anti-
bodies were subsequently depleted from the cell suspension using
anti-biotin MicroBeads and magnetic separation. The resulting
cell suspension contained>95% T-lymphocytes as assessed using
anti-CD3 staining. The cells were used after overnight incubation
in RPMI with 10% FCS at 37˚C and 5% CO2.
To generate primary murine T cells, peripheral lymph nodes
were harvested from C57Bl/6 mice (Jackson Labs). CD4+ T cells
were isolated by negative selection using anti-CD8 (2.43) and
anti-MHCII (M5/114.15.2). T cells were stimulated in 24-well
plates coated with 1µg/ml anti-CD28 (PV1) and anti-CD3 (2C11)
(both from BioXCell) for 3 days and maintained in DMEM supple-
mented with 5% FBS, penicillin, streptomycin, GlutaMAX, Hepes,
NEAA, and β-mercaptoethanol (all from Invitrogen) at 37˚C, 10%
CO2. T-lymphoblasts were then rested for 2 days before siRNA
suppression.
siRNA-MEDIATED PROTEIN SUPPRESSION AND CHEMOKINE
STIMULATION OF MURINE T CELLS
SiRNA duplexes against mouse flotillin-2 were purchased from
Dharmacon RNAi Technologies. SiGenome non-targeting control
siRNA #2 was used as a control. Cells were washed and resus-
pended in unsupplemented DMEM. T cells (107) were mixed
with 400 pmol of either control or flotillin-2 siRNA in 4 mm gap
cuvettes and transfected using a BTX ECM830 electroporator at
290 V for 10 ms. After transfection, T cells were maintained in
supplemented DMEM and 100 U/ml rhIL-2 (obtained through the
AIDS Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH from Dr. Maurice Gately, Hoffmann-La Roche Inc.)
for 48–72 h. For chemokine stimulation,48 h after electroporation,
cells were resuspended in PBS and warmed to 37˚C for 15 min.
10 nM SDF-1α (Peprotech), was added and cells were incubated at
37˚C for 15 min prior to lysis at 4˚C.
IMMUNOBLOTTING OF T CELLS
Murine T cells were lysed at 108 cells/ml in 1× RIPA buffer
(150 mM NaCl, 50 mM Tris pH 7.5, 1% NP40, 0.5% Na-
Deoxycholate, 10% glycerol, 0.1% SDS, 50 mM NaF, 1× Complete
mini protease inhibitors, and 1 mM NaVO4) for 20 min on ice.
Insoluble material was pelleted at 13,000 rpm for 20 min. Cells
were boiled in sample buffer and separated on a 10% acrylamide
Tris-glycine gel using SDS-PAGE electrophoresis. Proteins were
transferred to nitrocellulose and blocked in 5% BSA in PBS. Blots
were probed with antibodies specific for flotillin-1 or flotillin-
2 (BD Biosciences), total ERM proteins (BD Biosciences anti-
moesin), phospho-ERM proteins (Cell Signaling), and GAPDH
(Millipore) in TBST, followed by AlexaFluor680 donkey anti-
mouse IgG (Invitrogen) or IR800 goat-anti-rabbit IgG (Rockland).
Proteins were visualized and quantified using the Odyssey Imager
(LI-COR).
Human T cells were precipitated with trichloro acetic acid
(TCA), separated on a 10% gel and subjected to immunoblotting.
Blots were probed with antibodies specific to total ERM proteins or
phospho-ERM proteins (Cell Signaling), followed by a goat-anti-
rabbit IgG antibody coupled to horseradish peroxidase (BioRad)
as described (Rossy et al., 2009). Proteins were visualized using an
ECL Western detection system, detected with the LAS-4000 imag-
ing system (Fujifilm) and quantified with the Quantity one system
(BioRad).
TRANSIENT EXPRESSION OF PROTEINS IN HUMAN T CELLS
For transfections, 3–5× 106 freshly isolated T-lymphocytes were
resuspended in 100µl human T cell nucleofector solution (Lonza)
diluted 1:2 with PBS and 2–4µg of plasmid DNA were added. The
cell suspension and the plasmid DNA were then transferred to a
cuvette and nucleofection was carried out (Amaxa Nucleofector,
program U-14). Immediately, 500µl of medium with 20% FCS
was added and the T cells were transferred to a prewarmed 12-
well plate containing 2.5 ml of medium with 20% FCS, followed
by incubation at 37˚C in a CO2 incubator for 4 h. Transfected T
cells were subsequently washed, resuspended in Gey’s solution and
used for experiments. In order to assess expression levels of ezrin
constructs, the viable EGFP-positive cells were separated from the
viable non-fluorescent and dead cells using an ARIA III cell sorter
(BD Biosciences). The sorted cells were precipitated with TCA and
subjected to immunoblotting as described (Rossy et al., 2009).
IMMUNOFLUORESCENCE STAINING
Human T cells: cells were incubated in suspension in plastic tubes
in Gey’s buffer at 37˚C with agitation (750 rpm) without or with
stimuli (4–8× 106 cells/ml, 500µl per assay) as indicated in the
Figure legends. After incubation cells were fixed with 3.7% (final)
paraformaldehyde (PFA) for 10 min at 37˚C for visualization of
tagged ezrin constructs and for β-actin, or with TCA for visu-
alization of endogenous flotillin-2, ezrin, moesin, and P-ERM, as
described (Affentranger et al., 2011). The fixed T cells were washed
with PBS, cytocentrifuged, permeabilized with methanol (−20˚C,
3–5 min) for detection of β-actin and washed with PBS. Cells were
then incubated with the indicated primary antibodies followed
by incubation with the appropriate secondary antibodies (Alexa
488-conjugated goat-anti-rabbit or goat anti-mouse IgG antibod-
ies) as described (Affentranger et al., 2011). Images were taken
with an Olympus Fluoview FV1000-IX81 confocal laser scanning
microscope, using a 60× oil immersion objective. ERM-, flotillin-,
and PSGL-1-enriched aggregates located at the plasma membrane
of at least 1µm or larger (maximally approximately 4µm) were
defined as “caps.” For analysis of shape and protein localization,
50–100 T cells were analyzed per sample in all experiments.
Murine T cells: 12 mm round glass coverslips were acid washed
with 10% H2O2 in 0.1N HCL, rinsed in ddH2O followed by
methanol, and flame dried. Coverslips were coated with 50µg/ml
of human fibronectin (R&D Systems) for 2 h at RT. T cells
(1.5× 105) were resuspended in 50µl unsupplemented DMEM,
added to each coverslip and allowed to settle in a humidified
chamber for 30 min at 37˚C. Unbound cells were washed off and
bound T cells were fixed using 3% PFA/PBS and quenched with
50 mM ammonium chloride. To quantify uropod formation, at
least 50 randomly selected cells per coverslip were scored based
on an elongated shape and the presence of a distinct tail-like
structure. For staining of moesin, cells were permeabilized with
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0.1% Triton X-100 after fixation, blocked with 2% horse serum in
PBS and probed with rabbit anti-moesin, followed by Alexa Fluor
488 goat-anti-rabbit (Invitrogen). Cells were imaged using a Zeiss
Axiovert 200M microscope with a 63× objective. ERM polarity
was scored based on ERM localization in the uropod of polarized
cells, or to an area less than one third of the cell circumference of
unpolarized cells.
2D MIGRATION OF HUMAN T CELLS ON ENDOTHELIAL CELLS
Four to five days prior to the experiments, immortalized human
cerebral microvascular endothelial cells (hCMEC/D3) (Weksler
et al., 2005) at passage 32 were seeded on a 96 well plate
(Greiner Bio-one, catalog no 655090) (4× 104 cells per well) in
EBM-2 culture medium from Lonza (with 5% FCS, 1% Peni-
cillin/Streptavidin, 1.4µM Hydrocortisone, 5µg/ml Acid Ascor-
bic, 0.01% chemically defined lipid concentrate, 10 mM Hepes,
1 ng/ml basic FGF). 20 h prior to the experiment hCMEC/D3 cells
were stimulated with 20 ng/ml recombinant interleukin-1β (IL1β)
(PromoKine, Vitaris). 30 min prior to the experiment hCMEC/D3
were washed with culture medium to remove IL1β.
For live-cell imaging 750,000 T cells, resuspended in 75µl
RPMI-Hepes with 10% FCS, were pipetted into a well of a 96 well
plate containing 125µl EBM-2 with supplements and a confluent
monolayer of IL1β stimulated hCMEC/D3. T cells were allowed
to settle for 10 min at 37˚C. Then, the 96 well plate was mounted
on the heated stage of an inverted microscope (AxioObserver.Z1,
Carl Zeiss). Microscopic image acquisition was computer con-
trolled through the AxioVision 4.2 software (Carl Zeiss), using
the 20×/0.4 LD Plan-Neofluar objective. Images were taken with a
high resolution monochrome AxioCam RMm Rev Camera (four
images per min) for a time period of 10 min. For each condition
two consecutive image series were acquired at different positions
in the same well. Movies were created with eight frames per sec-
ond (1 s of movie= 2 min real time). For evaluation of the % of
migrating cells, the initial position of transfected T cells adhering
to the endothelial cells was outlined, and only cells that had com-
pletely left the initial outline were scored as migrating. The speed
of the migrating T cells was determined using Image J.
TRANSWELL CHEMOTAXIS
300,000 freshly isolated human T cells were transiently trans-
fected with EGFP or the indicated ezrin constructs and resus-
pended in 0.1 ml RPMI (lacking FBS) containing 1% BSA. The
cells were placed in Costar filter inserts with 3µm pore size and
allowed to migrate to the lower wells containing 0.6 ml RPMI
and 1% BSA with or without SDF-1 (200 ng/ml) for 1 h at 37˚C
and 5% CO2. The % of migrated transfected T cells was deter-
mined by PFA fixation of an aliquot of the input sample and
of the cells recovered in the lower wells and determination of
the total cell numbers and the % of transfected cells in each
sample.
FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING EXPERIMENTS
Human T-lymphocytes were transfected with WT or mutant ezrin
constructs and both flotillin-1 and -2 tagged with mCherry, fol-
lowed by a 4 h incubation at 37˚C in a CO2 incubator and a 15 min
incubation in the absence or presence of 40 ng/ml SDF-1 in Gey’s
medium containing 1 mM MgSO4, 1.1 mM CaCl2, and 5% BSA. A
5µl aliquot of cell suspension (10× 106 cells/ml) was then imme-
diately placed on a glass slide, covered with a glass coverslip and
sealed with hot paraffin. Live-cell confocal imaging was performed
at room temperature with a confocal laser scanning microscope
Olympus Fluoview FV1000-IX81, 60× oil immersion objective.
A picture of the cells was taken 2 s before bleaching of the EGFP
moiety. A circular region of interest (ROI) of 2.5µm in diameter
in the region of the flotillin-enriched cap (if present) was continu-
ously bleached at 8% of full laser power (473 nm for EGFP) for 12 s.
Seven seconds after the completion of bleaching the first frame was
taken. Fluorescence recovery was observed for 140 s (20 frames) at
0.5–1% laser power. For analysis the fluorescence of the bleached
ROIs, corrected for the reduction in fluorescence of control ROIs
located outside of the bleached area in the same cell which occurs
due to image capture, and normalized to the initial fluorescence in
the ROIs before bleaching, was plotted against time. The mobile
fraction was calculated after correction for bleaching of the con-
trol ROIs according to M F= (F FR− F 0)/F i− F 0) where F FR is
the average fluorescence after full recovery, F 0 is the fluorescence
immediately after the bleach, and F i is the fluorescence just before
photobleaching.
STATISTICAL ANALYSIS
Data were analyzed with the Graph Pad Prism software (ver-
sion 5.04) using ANOVA with Tukey’s post hoc testing or, for
the fluorescence recovery after photobleaching (FRAP) data, the
Kruskal–Wallis test with Dunn’s multiple comparison test, or for
the siRNA data, with the paired two-tailed t -test. P values< 0.05
were considered significant. Data correspond to the mean± SEM.
RESULTS
LOCALIZATION OF ENDOGENOUS ERM PROTEINS AND FLOTILLINS IN
HUMAN FRESHLY ISOLATED T CELLS
As a first step toward understanding how ERM proteins and
flotillins function to promote uropod organization, we asked
where endogenous ERM proteins are located in freshly isolated
T cells as compared to flotillins and to what extent their loca-
tion correlates with that of the activated, P-ERM proteins. Human
freshly isolated T-lymphocytes express mainly ezrin and moesin
(approximately 20 and 80% of total ERM proteins, respectively).
Both ezrin and moesin react with an antibody selective for P-
ERM in immunoblots (Figure 1A). In agreement with previous
data obtained with freshly isolated human T cells (Brown et al.,
2003), stimulation with SDF-1 results in rapid (but not com-
plete) dephosphorylation of moesin and ezrin, down to 18 and
5% respectively of the values prior to addition of chemokine
(Figures 1B,C). We analyzed the localization of endogenous total
and P-ERM proteins and of flotillins in human T cells. Endoge-
nous ezrin and moesin show mainly a random punctate cortical
location in resting T cells, partially colocalizing with endoge-
nous flotillin-2 (Figures 1D,E). In chemokine-stimulated cells,
ezrin and moesin are present in the uropod, but also show a
diffuse location, in contrast to endogenous flotillin-2, which is
almost exclusively located in the uropods (Figures 1D,E). Stain-
ing of resting cells with an antibody reacting exclusively with
phosphorylated, activated ERM proteins also indicates a random
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FIGURE 1 | Expression and localization of endogenous ERM proteins in
humanT cells. (A) Freshly isolated human T cells (1×106 cells per lane)
were precipitated with TCA and subjected to immunoblotting (7.5% gel)
using polyclonal rabbit antibodies directed against ezrin, moesin, all ERM
proteins, or P-ERM, as indicated. (B) T cells were incubated in the absence
or presence of 40 ng SDF-1/ml for the specified times, followed by
precipitation with TCA and immunoblotting using an antibody recognizing
P-ERM, and as loading control, an antibody recognizing all ERM proteins
independent of phosphorylation. (C) Quantitative evaluation of the
experiment shown in (B) obtained by densitometry (ratio of values obtained
for phosphorylated moesin or ezrin, divided by values obtained for total
moesin or ezrin). Mean±SEM of four independent experiments.
***P < 0.001 for statistically significant differences to cells not exposed to
SDF-1. (D–F) T cells were preincubated for 15 min at 37˚C in the absence of
stimuli, followed by a further incubation for 15 min in the absence or
presence of 40 ng/ml SDF-1 as indicated. T cells were then fixed and stained
for ezrin (D), moesin (E), or P-ERM (F) using the same antibodies as in (A),
and for flotillin-2 using monoclonal antibodies, followed by confocal
microscopy (dic: differential interference contrast). Asterisks indicate cells
that are shown enlarged in the panel at the bottom. Bar, 10µm.
cortical location. Upon stimulation with the chemokine SDF-1,
the remaining P-ERM proteins show a marked accumulation in
the uropod, partially colocalizing with flotillin-2 (fluorescence pic-
tures: Figure 1F). Of the stimulated T cells with accumulation of
flotillin-2 in the uropod, 59± 9% (n= 3) also have P-ERM caps
whereas 98± 1% of the T cells with P-ERM caps have flotillin-2
caps. These results are in agreement with our previous data in
human T-lymphoblasts (Affentranger et al., 2011). The data sug-
gest that in chemokine-stimulated cells only a small fraction of
the ERM proteins is in the activated phosphorylated state and
that activated P-ERM proteins preferentially accumulate in the
uropod.
T CELL POLARITY IS AFFECTED BY THE ACTIVATION STATE OF EZRIN
In order to test the role of ERM proteins in polarization and
uropod scaffolding,we interfered with the functions of the endoge-
nous ERM proteins by transiently transfecting freshly isolated
human T cells with ezrin WT or mutants, all tagged at the C-
terminus with EGFP. T567D ezrin mimics the phosphorylated
form and is thus constitutively active. Conversely, the N-terminal
1–310 ezrin truncation mutant encodes only the FERM domain,
and has widely been used to interfere with the function of all ERM
proteins, presumably by uncoupling receptors from the cortical
actin network (Martin et al., 1995; Faure et al., 2004). The amounts
of expressed tagged proteins relative to the endogenous ezrin are
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documented in Figure 2. The majority (95± 3%) of cells tran-
siently transfected with EGFP alone are spherical in the absence of
the chemokine SDF-1. Addition of SDF-1 induces T cell polariza-
tion in 91± 1% of the EGFP-expressing cells (Figures 3A,C). WT
ezrin-EGFP shows a uniform peripheral location in resting cells.
In chemokine-stimulated cells, WT ezrin-EGFP shows a cortical
but also cytosolic diffuse location (Figure 3A). In a small fraction
(16± 2%) of the cells, WT ezrin-EGFP is capped in the uropod
(Figure 3B). Quantitative evaluation of these experiments shows
that transfection with WT ezrin-EGFP, as compared to EGFP, does
not modify cell polarization in the absence or presence of SDF-1
(Figure 3C). Interestingly, however, transfection of T cells with
the constitutively active T567D ezrin-EGFP induces cell polar-
ization in 33± 8% of the transfected cells even in the absence
of SDF-1. In these polarized T cells, T567D ezrin-EGFP local-
izes exclusively in the contracted uropod, opposite to β-actin-rich
ruffles (Figures 3A,C). Transfection of T567D ezrin-EGFP does
not further modify T cell polarization in SDF-1-stimulated cells.
Conversely, the dominant-negative 1–310 ezrin mutant shows
a random peripheral location and does not cap at all upon
SDF-1-stimulation. Moreover, this construct markedly inhibits
FIGURE 2 | Analysis of expression of wild type and mutant ezrin
constructs in humanT cells in relation to endogenous ezrin. T cells
were transiently transfected with the indicated constructs and
EGFP-expressing T cells were sorted by FACS. The sorted cells were
precipitated with TCA and subjected to immunoblotting, using an antibody
reacting with the N-terminal domain of ezrin diluted 1:2000. The open arrow
indicates endogenous ezrin (approximately 80 kDa); the closed arrow
indicates the EGFP-tagged full-length proteins (approximately 110 kDa) and
the arrowhead indicates the EGFP-tagged N-terminal ezrin fragment
(approximately 60 kDa). Numbers at the left indicate molecular masses
(kDa) of standard proteins. Quantitative evaluation of this blot indicates that
WT ezrin-EGFP is overexpressed by 210% and T567D ezrin-EGFP by 335%
as compared to endogenous ezrin. 1–310 ezrin-EGFP shows a substantially
lower expression (approximately 10% of the endogenous ezrin).
FIGURE 3 | Localization of tagged ezrin constructs in humanT cells,
and impact of expression of ezrin constructs on cell morphology. (A–C)
T-lymphocytes were transfected either with wild type (WT) ezrin-EGFP,
T567D ezrin-EGFP, or 1–310 ezrin-EGFP. Four hours after transfection, cells
were incubated in the absence or presence of SDF-1, as described in the
legend of Figure 1D, followed by fixation with PFA and staining for
β-cytoplasmic actin. Bar, 10µm. (A) Fluorescence pictures obtained by
confocal microscopy; (B) quantitative evaluation of the % of transfected T
cells with capped EGFP-tagged wild type or mutant ezrin (mean±SEM of
three to five independent experiments); (C) quantitative evaluation of the %
of transfected T cells with front-tail polarity (mean±SEM of three to four
experiments; exception: EGFP: n=2). (B,C) *P <0.05; **P <0.01;
***P <0.001 for statistically significant differences between data as
indicated.
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SDF-1-induced cell polarization by 57± 7% (n= 3) (Figure 3C).
T cells expressing the 1–310 ezrin mutant and stimulated with
SDF-1 still exhibit some β-actin-rich ruffles, with little colocaliza-
tion of the ezrin construct and β-actin (Figure 3A). These findings
strongly suggest that ERM protein function is needed for efficient
chemokine-induced T cell polarization, and that in some cells,
expression of active ERM proteins is sufficient to induce uropod
formation.
EZRIN ACTIVATION STATE IMPACTS THE UROPOD LOCALIZATION OF
FLOTILLINS AND PSGL-1
As previously shown, flotillins are required for efficient T cell
uropod formation and capping of PSGL-1. Capping of flotill-
ins and PSGL-1 correlates with cell polarization (Affentranger
et al., 2011). Since transfection with T567D ezrin induces T cell
front-tail polarity and formation of F-actin-rich ruffles, and 1–
310 ezrin suppresses cell polarization, we were interested to know
whether these mutants also impact uropod capping of flotillins
and PSGL-1. As shown in Figures 4 and 5, the majority of T
cells transiently transfected with EGFP alone are spherical and
lack flotillin and PSGL-1 caps in the absence of SDF-1. Note
that EGFP enters the nucleus, whereas the ezrin constructs are
excluded from the nucleus. Addition of chemokine induces uro-
pod capping of PSGL-1 and flotillins in 92± 1 and 94± 5% of the
T cells respectively (Figure 4, quantified in Figure 5). Transfec-
tion with WT ezrin-EGFP, as compared to EGFP, does not modify
localization of PSGL-1 and flotillins in the absence or presence
of SDF-1. In contrast, transfection of cells with the constitutively
active T567D ezrin-EGFP significantly induces flotillin and PSGL-
1 capping in 32± 2% of the transfected T cells even in the absence
of SDF-1. Capping of flotillins and PSGL-1 occurs only in T cells
with capped T567D ezrin. In some cells expressing T567D ezrin,
the uropod is enlarged, comparable to the findings of Lee et al.
(2004). Expression of T567D ezrin-EGFP does not further mod-
ify protein capping in SDF-1-stimulated T cells as compared to
T cells expressing WT ezrin. T567D ezrin-EGFP shows a marked
colocalization with PSGL-1 and flotillins in the uropods. Con-
versely, dominant-negative 1–310 ezrin-EGFP partially prevents
capping of flotillin and PSGL-1. Specifically, capping of PSGL-1
is inhibited by 54± 5% (n= 3), as compared to T cells trans-
fected with WT ezrin. The effect on flotillin capping is smaller
but also statistically significant (inhibition: 35± 9%, n= 4). Thus,
expression of constitutively active ezrin induces front-tail polarity
and capping of flotillins and PSGL-1 to a similar extent, whereas
the dominant-negative ezrin mutant has a comparable inhibitory
effect on uropod formation and capping of uropod proteins.
siRNA-MEDIATED SUPPRESSION OF FLOTILLIN-1 AND -2 IN MURINE
T-LYMPHOBLASTS IMPAIRS MOESIN CAPPING AND UROPOD
FORMATION
We showed previously that transfection of human T-lymphoblasts
with a dominant-negative mutant of flotillin-2 impairs cell polar-
ization and capping of endogenous flotillin-1 and PSGL-1 (Affen-
tranger et al., 2011). We therefore asked whether interference with
flotillin expression also modifies capping of activated ERM pro-
teins. To this end, we performed siRNA-mediated suppression of
flotillin-2 expression. These experiments were done in murine T
cells, since flotillin suppression in these cells was more efficient
than in human T cells where we could achieve maximally approx-
imately 30% downregulation. Using flotillin-2 specific siRNA in
murine T-lymphoblasts, expression of both flotillin-1 and -2 could
be suppressed by about 53 and 65%, respectively (Figure 6A). This
agrees with previous findings in other cell types, that the stability
of flotillin-1 depends on that of flotillin-2 (Solis et al., 2007). ERM
protein levels are unaffected, demonstrating specificity of sup-
pression (Figure 6B). In murine T cells, about 50% of the ERM
proteins are phosphorylated (Shaffer et al., 2009) and flotillin sup-
pression has no effect on basal levels of ERM phosphorylation
or on patterns of chemokine-stimulated ERM dephosphoryla-
tion (Figure 6B and data not shown). Moesin shows appreciable
capping in T-lymphoblasts adhering to fibronectin-coated glass
(Figure 6C). Moesin capping is significantly reduced by 46± 9%
(n= 4) in cells with reduced flotillin expression. Similarly, uropod
formation is reduced by 56± 8% (n= 4) in cells with downregu-
lated flotillins (Figures 6D,E), indicating that flotillins and ERM
proteins cooperate in uropod scaffolding and formation.
UROPOD FORMATION INDUCED BY T567D EZRIN IS PERTURBED BY
DISRUPTION OF THE ACTO-MYOSIN CYTOSKELETON IN HUMAN T
CELLS
Myosin contractility, activated by Rho-kinase activity, is essential
for uropod contraction in chemokine-stimulated T-lymphoblasts,
but is not required for capping of flotillins and PSGL-1 (Affen-
tranger et al., 2011). To test the relationship between polarization
induced by constitutively active T567D ezrin and the acto-myosin
cytoskeleton, we used Y-27632, blebbistatin, and latrunculin A
as inhibitors of Rho-kinase, myosin II, and F-actin, respectively.
Treatment of human T cells with Y-27632 or blebbistatin does
not significantly affect cap formation of T567D ezrin-EGFP in the
absence or presence of SDF-1 (Figures 7A,B). However formation
of a contracted uropod in cells transfected with T567D ezrin-EGFP
in the absence or presence of SDF-1 is inhibited significantly by
approximately 50% by these inhibitors (Figures 7A,C), indicat-
ing a role of myosin II and Rho-kinase. We also investigated the
impact of Y-27632 and blebbistatin on capping of endogenous P-
ERM and flotillin-2. As shown in Figure 8A, endogenous flotillin
caps in SDF-1-stimulated freshly isolated T cells are relatively resis-
tant to these inhibitors (16± 6% reduction of flotillin-2 caps by
Y-27632; 21± 7% reduction by blebbistatin). In contrast, SDF-
1-induced capping of endogenous P-ERM proteins is markedly
reduced (Figure 8B; 67± 8% inhibition by Y-27632; 73± 7% inhi-
bition by blebbistatin). Moreover, SDF-1-induced formation of
contracted uropods is completely abolished by both inhibitors
(Figure 8C). The inhibitory effects of Y-27632 and blebbistatin
on P-ERM capping could be explained by a reduction in ERM
phosphorylation in cells treated with these drugs. However, as
shown in Figures 8D–F, preincubation of T cells with either Y-
27632 or blebbistatin does not prevent P-ERM dephosphorylation.
Indeed, we observed significant increases in phosphorylation of
both ezrin and moesin both before and after chemokine addition.
Thus, as reported previously (Belkina et al., 2009), Rho-kinase
does not appear to play an important role in phosphorylating T
cell ERM proteins. Rather, both active Rho-kinase and myosin
II appear to negatively regulate ERM phosphorylation. On the
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FIGURE 4 | Impact of expression of ezrin constructs on localization
of PSGL-1 and flotillins in humanT cells. (A) T cells were transfected
either with EGFP, wild type (WT) ezrin-EGFP, T567D ezrin-EGFP, or
1–310 ezrin-EGFP as indicated. Four hours after transfection, T cells
were incubated in the absence or presence of SDF-1, as described in
the legend of Figure 1D, followed by fixation with PFA, staining for
PSGL-1 using a monoclonal antibody and confocal microscopy. Bar,
10µm. (B) All T cells were cotransfected with flotillin-1-mCherry and
flotillin-2-mCherry (singly expressed flotillins do not cap) and either with
EGFP, wild type ezrin-EGFP, T567D ezrin-EGFP, or 1–310 ezrin-EGFP as
indicated. Four hours after transfection, T cells were incubated in the
absence or presence of SDF-1 as described in the legend of Figure 1,
followed by fixation with PFA. Bar, 10µm. White arrowheads indicate
contracted uropods.
basis of these results, we conclude that Rho-kinase and myosin
activity are required for uropod formation independently of ERM
phosphorylation.
Prevention of actin polymerization by treatment of T cells
with latrunculin A completely abolishes both T567D ezrin cap
formation and uropod formation in the absence and presence
of SDF-1, indicating an important role of the cortical F-actin
in capping of overexpressed constitutively active ezrin and in
induction of polarization (Figure 7). In order to obtain more
information on the role of actin in capping and immobilization
of ezrin, we analyzed the lateral mobility of T567D ezrin-EGFP,
as compared to WT ezrin-EGFP, in T cells using FRAP. Note
that these FRAP experiments were carried out at 20˚C, as rapid
shape changes and migration occurring at 37˚C precluded accurate
bleaching, acquisition and evaluation of FRAP data. The T cells
were cotransfected with flotillin-1 and -2 tagged with mCherry
as uropod markers (singly expressed flotillins do not cap, see
Baumann et al., 2012) and bleaching of EGFP was carried out
in the region of flotillin caps, if present. As shown in Table 1,
75% of T567D ezrin-EGFP is immobilized in cells not exposed
to SDF-1, as compared to only 26% of WT ezrin. Mobility of
T567D ezrin-EGFP is significantly (P < 0.01) restored by pre-
treatment with latrunculin A to values obtained for WT ezrin,
indicating immobilization due to F-actin interaction. Similar data
were obtained for cells treated with SDF-1. In contrast, the major-
ity of the WT ezrin-EGFP molecules are mobile, irrespective of
the presence or absence of latrunculin A or SDF-1 (Table 1).
This finding correlates with the observation that WT tagged ezrin
does not cap significantly in the uropod in SDF-1-stimulated
cells (Figure 3). Thus only a small fraction of total ezrin appears
to be phosphorylated/activated and capable of interacting with
F-actin.
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FIGURE 5 | Impact of expression of ezrin constructs on localization of
PSGL-1 and flotillins in humanT cells: quantitative evaluation. (A) The
fraction of transfected T cells with PSGL-1 caps was evaluated for the
experiment shown in Figure 4A (mean±SEM of three to four experiments¸
exception: EGFP: n=2). (B) The fraction of transfected T cells with
flotillin-mCherry caps was evaluated for the experiment shown in Figure 4B
(mean±SEM of four to five experiments¸ exception: EGFP: n=2). Open bars:
incubation for 30 min without SDF-1; closed bars: stimulation with SDF-1 for
15 min. *P <0.05; **P <0.01; ***P <0.001 for statistically significant
differences between data as indicated.
EXPRESSION OF T567D EZRIN PROMOTES T CELL MIGRATION IN THE
ABSENCE OF ADDED CHEMOKINE, WHEREAS 1–310 EZRIN
ATTENUATES THIS PROCESS
Cell polarization is a prerequisite for migration. Since expression
of T567D ezrin enhances cell polarization and that of 1–310 ezrin
attenuates polarization, we assessed the impact of these constructs
on migration, in comparison to WT ezrin. For this purpose, we
measured random spontaneous 2D T cell migration in the absence
of added chemokine on IL1β-stimulated human endothelial cell
layers, which express adhesion molecules such as ICAM-1. As
shown in Figure 9A, only 7± 3% of T cells expressing EGFP and
8± 2% of T cells expressing WT ezrin migrate in this assay,whereas
19± 3% of the T cells expressing T567D ezrin are migratory.
Analysis of the fractions of migrating cells revealed a signifi-
cant 2.7± 0.6-fold increase (n= 3, P < 0.05) when comparing
T cells expressing WT ezrin and T567D ezrin, and a 4.3± 1.6-
fold increase (n= 3, P < 0.01) when comparing T cells expressing
EGFP and T567D ezrin. The mean speed of the migrating T cells is
not significantly different for cells transfected with any of the ezrin
constructs (Figure 9B). T cells expressing T567D ezrin and sponta-
neously migrating on IL1β-stimulated endothelial cell layers in the
absence of chemokine are shown in Movie S1 in Supplementary
Material. Occasionally we observed migrating cells that simultane-
ously changed their polarity, as well as the position of the T567D
ezrin cap in the rear and the direction of migration during the
movie. One such cell is shown in this movie (cell on the right).
In a separate series of experiments, we assessed the impact of
1–310 ezrin expression in comparison to T cells transfected with
EGFP or WT ezrin. As shown in Figure 9C, transfection of T cells
with 1–310 ezrin results in a 45± 11% (n= 3, P < 0.05) reduction
in the fraction of migrating cells as compared to cells trans-
fected with WT ezrin, and a 44± 16% (n= 3, P < 0.05) reduc-
tion as compared to T cells transfected with EGFP. As with cells
expressing the constitutively active ezrin, migrating cells express-
ing the dominant-negative 1–310 mutant do not show significant
changes in speed (Figure 9D). Note that in the second series of
experiments shown in Figures 9C,D, the fraction of spontaneously
migrating cells transfected with EGFP or WT ezrin was somewhat
increased as compared to the first series shown in Figures 9A,B
due to biological variations in the experimental system.
EXPRESSION OF 1–310 EZRIN ATTENUATES T CELL CHEMOTAXIS
In addition to analyzing random cell migration, we also investi-
gated SDF-1-induced chemotaxis. Transfection of human T cells
with WT or T567D ezrin does not significantly modify SDF-1-
induced migration through 3µm transwell filters as compared to
transfection with EGFP alone (Figure 9E). In contrast, transfec-
tion with 1–310 ezrin reduces chemotaxis significantly (inhibi-
tion: 53± 5%, n= 8, as compared to cells expressing WT ezrin)
(Figure 9E), in agreement with the findings for 2D migration
(Figures 9C,D). These data correlate with the negative effect of
this construct on cell polarity (Figure 3). The reduction in chemo-
taxis as a result of 1–310 ezrin expression is similar in magnitude
to the reduction in polarized cells and cells with capped flotillins
(Figures 3–5). Little migration is observed when SDF-1 is present
both in the upper and the lower wells, indicating predominant
chemotactic (and not chemokinetic) migration (Figure 9E).
DISCUSSION
We provide here novel data showing that expression of activated
ezrin in primary human T cells is sufficient to induce polarization
responses involving formation of a contracted uropod enriched
in membrane-microdomain-associated flotillins and the adhesion
receptor PSGL-1, as well as a leading edge bearing β-actin-rich
ruffles. These T cells are capable of migration in the absence of
added chemokine and chemotax normally in a gradient of SDF-1.
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FIGURE 6 | Reduction of flotillin-1 and -2 expression in murine
T-lymphoblasts impairs moesin capping and uropod formation. Murine
T-lymphoblasts were treated with control siRNA (siC ) or siRNA directed
against murine flotillin-2 (siF). (A) Downregulation of both flotillin-1 and -2
was assessed by immunoblotting. (B) Murine T-lymphoblasts prepared as in
(A) were untreated or treated with 10 nM SDF-1α for 15 min, and lysates
were immunoblotted for total or P-ERM proteins. Relative phosphorylation
of ezrin and moesin was obtained by densitometry (ratio of values obtained
for phosphorylated moesin or ezrin, divided by values obtained for total
moesin or ezrin, and normalized to the control sample). Data are from one
experiment, representative of three. Note that the low signal in the siF
+SDF-1 lane is due to underloading and is not reproducibly observed. (C–E)
T cells prepared as in (A) were allowed to adhere to fibronectin-coated glass,
fixed and stained for moesin (C) and the % of cells with moesin caps (D)
and uropods (E) was evaluated. Bar, 10µm. (D,E) Mean±SEM of four
experiments; *P <0.05.
T567D ezrin does not significantly modify polarization or chemo-
taxis of SDF-1-stimulated cells. Conversely, dominant-negative
1–310 ezrin had no impact on the morphology of resting cells,
but significantly reduced polarization, capping of flotillins and
PSGL-1 and chemotaxis of SDF-1-stimulated cells. These data
strongly suggest an important positive role of ERM proteins in
self-organizing T cell polarity, particularly with respect to uro-
pod formation and uropod recruitment of adhesion receptors
and membrane-microdomain scaffolding proteins such as flotill-
ins. We also show that downregulation of flotillins in murine
T cells impairs moesin capping and uropod formation without
perturbing ERM protein phosphorylation. Together, these find-
ings suggest that ERM proteins and flotillins mutually enhance
uropod capping and cooperate in uropod formation. Our findings
are in agreement with data obtained for a constitutively polarized
murine lymphoma cell line, where transfection with T567D ezrin
increased uropod size, whereas 1–310 ezrin reduced the fraction
of cells with uropod (Lee et al., 2004). Interestingly, in that study
T567D ezrin induced capping of CD44, but not uropod forma-
tion in a naturally unpolarized myeloma cell line, indicating that
in these cells the machinery for uropod formation is lacking, in
contrast to the T cells used in our study.
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FIGURE 7 | Impact of cytoskeletal perturbation on capping of
T567D ezrin-EGFP and on humanT cell front-tail polarity induced
byT567D ezrin-EGFP. (A–C) T cells were transfected with T567D
ezrin-EGFP. Four hours after transfection, cells were preincubated in
the absence or presence of 20µM Y-27632 (Y) (to inhibit Rho-kinase)
or 50µM blebbistatin (ble) (to inhibit myosin II) or 1µM latrunculin A
(lat) (to disrupt F-actin), followed by a further incubation in the
absence or presence of SDF-1 (40 ng/ml) for 15 min. T cells were then
fixed with PFA, followed by confocal microscopy (A). The % of
transfected cells with T567D ezrin-EGFP caps (B) and the % of
transfected cells with contracted uropods (C) was evaluated. Bar,
10µm (B,C): mean±SEM of three to seven independent
experiments). *P <0.05; ***P <0.001 for statistically significant
differences between data as indicated.
We recently investigated chemotaxis, adhesion, and homing of
murine T-lymphoblasts lacking ezrin and with markedly reduced
moesin expression (Chen et al., 2013). In agreement with this work
on naive human T cells, in vitro chemotaxis to CCL19 of these T-
lymphoblasts deficient in ERM proteins through 3µm pores was
reduced by 20–50%. However no difference to WT cells could be
detected concerning chemotaxis through 5µm pores or migra-
tion in collagen gels. Defects in front-tail polarity could only be
detected in ERM-deficient T-lymphoblasts plated on β1-integrin
ligands, but not on β2-integrin ligands. Possibly the small amounts
of residual moesin in these cells may explain the moderate pheno-
type of these T-lymphoblasts. Alternatively, naive T cells may rely
more on ERM proteins than T-lymphoblasts.
Liu et al. (2012) investigated the migration of murine T-
lymphoblasts cultured from transgenic mice expressing low levels
of phosphomimetic T567E ezrin. There, in contrast to our data,
expression of T567E ezrin reduced cell polarization and protru-
sion formation. This discrepancy may be due to differences in the
extent of overexpression and/or to the use of murine expanded T-
lymphoblasts (Liu et al., 2012) versus freshly isolated human T cells
(this work). Liu et al. (2012) observed an increase in membrane
tension in T cells expressing T567E ezrin (about 50% of endoge-
nous ezrin) and proposed that this was responsible for reducing
protrusion formation. In contrast, we found that transfection
of human T cells with T567D ezrin (about 335% of endoge-
nous ezrin) actually enhanced protrusion and polarization. In our
hands, polarity was observed only in cells with capped T567D
ezrin; not in cells with randomly located T567D ezrin. In the
cells with capped T56D ezrin, rigidity of the cell cortex might
be enhanced locally, so that the formation of protrusions is sup-
pressed in one region of the cell. This still would allow or possibly
even promote localized protrusion formation on the opposite side
of the cap where T567D ezrin is lacking (Figure 3). Possibly, sub-
stantial capping of T567D ezrin only occurs at higher expression
levels. Further, Liu et al. (2012) report that in vitro chemotaxis and
migration of murine T-lymphoblasts expressing T567E ezrin on
ICAM-1 coated surfaces was inhibited by about 20% as compared
to cells transfected with WT ezrin. In our study we did not observe
a significant difference in in vitro chemotaxis between human T
cells expressing T567D ezrin as compared to cells transfected with
WT ezrin (Figure 9).
We show that although formation of a contracted uropod
requires an intact cytoskeleton and myosin II activity, spontaneous
capping of T567D ezrin requires F-actin but not myosin II activ-
ity or Rho-kinase activity (Figure 7). The requirement for F-actin
may be explained by spontaneous actin flow, which may promote
accumulation of T567D ezrin at one side of the cell. Retrograde
F-actin flow has been shown to occur in T cells independently
of myosin II activity (Babich et al., 2012). Indeed, T567D ezrin
appears to be immobilized by interaction with F-actin, as shown
by our FRAP experiments, in contrast to WT ezrin which is much
more mobile (Table 1). Uropod formation induced by T567D ezrin
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FIGURE 8 | Impact of cytoskeletal perturbation on capping of
endogenous flotillin-2 and P-ERM and on humanT cell front-tail polarity
induced by SDF-1. (A–C) T cells were preincubated for 30 min in the absence
or presence of 20µM Y-27632 or 50µM blebbistatin or 1µM latrunculin A,
followed by a further incubation in the absence or presence of SDF-1
(40 ng/ml) for 15 min. T cells were then fixed with TCA and stained for
flotillin-2 and P-ERM. The % of T cells with flotillin-2 caps (A) and P-ERM caps
(B) and the % of cells with front-tail polarity featuring contracted uropods (C)
was evaluated (mean±SEM of three independent experiments). *P < 0.05,
**P <0.01, for statistically significant differences between data as indicated.
(D–F) T cells were treated with Y-27632 or blebbistatin and SDF-1 as described
for (A–C), followed by precipitation with TCA and immunoblotting using an
antibody recognizing P-ERM, and as loading control, an antibody recognizing
all ERM proteins independent of phosphorylation. (D) shows a representative
immunoblot. (E,F) Quantitative evaluation of the experiment shown in
(D) obtained by densitometry. (Ratio of values obtained for phosphorylated
moesin or ezrin, divided by values obtained for total moesin or ezrin).
Mean±SEM of three to four independent experiments. *P <0.05;
**P < 0.01; ***P <0.001 for statistically significant differences between data
as indicated.
in the absence of chemokine is markedly reduced (but not abol-
ished) by inhibition of Rho-kinase or myosin II activity (Figure 7).
Similarly, inhibition of Rho-kinase or myosin II impairs uropod
formation in SDF-1-stimulated T cell without reducing phospho-
rylation of endogenous ERM proteins (Figure 8). This indicates
that Rho-kinase and myosin II activity are required for uropod
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Table 1 | Lateral mobility of wild type ezrin andT567D ezrin-EGFP
assessed with fluorescence recovery after photobleaching (FRAP) in
humanT cellsa.
Ezrin construct Pretreatment MF−SDF-1 (n) MF+SDF-1 (n)
WT ezrin-EGFP No pretreatment 0.74±0.06 (10) 0.64±0.11 (6)
WT ezrin-EGFP Latrunculin A
(1µM, 30 min)
0.81±0.06 (10) 0.79±0.07 (10)
T567D ezrin-EGFP No pretreatment 0.25±0.05 (11) 0.18±0.02 (10)
T567D ezrin-EGFP Latrunculin A
(1µM, 30 min)
0.72±0.06 (10) 0.81±0.03 (9)
aHumanT cells were cotransfected with wild type (WT) ezrin orT567D ezrin-EGFP
and with flotillin-1 and -2 tagged with mCherry. FRAP analysis involving local
bleaching of EGFP in the area of the flotillin caps was carried out as described in
the Section “Materials and Methods” with T cells preincubated in the absence
or presence of SDF-1 (15 min, 40 ng/ml) and without or with pretreatment with
latrunculin A as indicated. The mobile fraction (MF) was calculated for each indi-
vidual cell and then averaged from a total of n=9–11 cells observed in three
independent experiments (mean±SEM).
contraction independently of the state of ERM phosphorylation.
Constitutively active T567D ezrin could locally enhance Rho activ-
ity and thus myosin II activity and uropod contraction, in line with
previous findings (Ivetic and Ridley, 2004; Lee et al., 2004; Luo
et al., 2012). In addition, localized Rho activation in the T567D
ezrin caps may locally inactivate Rac, resulting in relative Rac
activation in other parts of the cell that then would promote for-
mation of F-actin-rich protrusions in the front. A similar process
has been proposed to occur in zebrafish neutrophils treated with
microtubule depolymerizing agents that induce Rho activation
and promote polarization and migration (Yoo et al., 2012).
Based on the currently available data, we postulate that the
following sequence of events occurs during chemokine-induced
T cell polarization: in resting T cells, uniformly membrane-
associated P-ERM prevents the formation of protrusions at the
plasma membrane by stabilizing a cortical actin network. Acti-
vation induces dephosphorylation of ERM proteins and dis-
sociation from the cortical actin, allowing formation of pro-
trusions in all directions. Later, the remaining activated ERM
proteins accumulate in the uropod driven by actin flow, where
they locally reinforce cortical F-actin, prevent protrusions, acti-
vate Rho/contractility, and act as scaffolding proteins, together
with flotillins. In this context it is interesting that data obtained
for neutrophils derived from mice lacking flotillin-1 indicate a
role for flotillin microdomains in enhancing myosin II activ-
ity (Ludwig et al., 2010). Other proteins may also contribute
to T cell uropod scaffolding, for example polarity proteins such
as Scribble, Par3, and Crumbs complexes that regulate epithe-
lial polarity. Interestingly proteins from these complexes are also
expressed in T cells, and downregulation of expression of Scribble
in the MD45 T cell line results in reduction of uropod formation,
ERM uropod location and migration (Ludford-Menting et al.,
2005).
Concerning the relationship between flotillins and P-ERM, our
data suggest that these proteins mutually reinforce their uropod
location by an as yet unknown mechanism. Based on our data,
enhancement of P-ERM uropod enrichment by flotillins does not
involve a role of flotillins in regulating ERM phosphorylation. We
tested whether flotillins and ERM proteins co-immunoprecipitate
using lysates of human T cells but could not find any positive evi-
dence for this (Baumann and Niggli, unpublished observations).
A possible link between flotillins and ERM proteins could be the
transmembrane receptor PSGL-1, a well established interaction
partner of ERM proteins (Ivetic and Ridley, 2004). We obtained
evidence for flotillin-PSGL-1 interactions in human neutrophils
using co-immunoprecipitation (Rossy et al., 2009). Moreover our
recent findings using the proximity ligation assay (PLA) also sug-
gest such an interaction to occur in freshly isolated human T cells.
The in situ PLA is based on modified secondary antibodies reacting
with murine or rabbit IgG. These secondary antibodies are con-
jugated with different oligonucleotides. Annealing of the probes
occurs when the target proteins are in close proximity (less than
30–40 nm distance), which then initiates the amplification. The
amplicons can be detected by fluorescence microscopy (Söder-
berg et al., 2006). Using polyclonal rabbit antibodies directed to
flotillin-2 and murine monoclonal antibodies directed to PSGL-
1 we detected PLA amplicons randomly distributed along the
plasma membrane in 81–83% of freshly isolated human T cells
incubated in the absence of chemokine. In 82–93% T cells stim-
ulated for 15 min with SDF-1 the amplicons were concentrated
in the uropod, at the plasma membrane, whereas in controls
only using the anti-flotillin-2 antibody, fluorescent dots could
be detected in less than 5% of the T cells (Baumann et al.,
unpublished observations). Thus flotillins could recruit PSGL-1
which in turn would enhance capping of P-ERM, and vice versa.
Another link could be a lipid intermediate. ERM proteins inter-
act with PIP-2-rich membranes (Niggli and Rossy, 2008), and
a significant pool of ERM proteins has been detected in lipid
raft fractions of T cells (Tomas et al., 2002) where flotillins also
reside (Rajendran et al., 2009). Cholesterol-rich microdomains
have been shown to be enriched in the uropod of human T-
lymphoblasts, and disruption of these microdomains by methyl-
β-cyclodextrin disrupt uropod formation and impair chemotaxis
(Millán et al., 2002). The possible role of flotillins in modulating
recruitment of ERM and other uropod proteins such as PSGL-
1 to uropod rafts requires further studies. It has to be noted
that inhibition of Rho-kinase or myosin II in SDF-1-stimulated
T cells markedly reduces capping of endogenous P-ERM by 67–
73%, without inhibiting ERM phosphorylation, but only reduces
capping of endogenous flotillin-2 by 16–21%. Thus, although
transfection with T567D ezrin is sufficient to induce capping
of flotillins, endogenous flotillins can cap without concomitant
P-ERM capping. In keeping with this, 93% of the chemokine-
stimulated T cells have flotillin-2 caps in the uropod, but only
61% exhibit P-ERM caps (Figure 8). Thus, it appears that activated
ERM proteins are not absolutely required for flotillin uropod cap-
ping and that flotillin capping does not obligatorily induce P-ERM
capping.
The N-terminal cargo-binding domain of 1–310 ezrin inhibits
ERM protein function in many systems, and here we find that
it inhibits T cell polarity responses. This truncated protein may
work in several ways. Faure et al. (2004) reported that trans-
fection of T cells with 1–310 ezrin causes dephosphorylation of
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FIGURE 9 | Impact of expression of ezrin constructs on random
humanT cell migration and chemotaxis. (A,B) T cells were
transfected with EGFP or wild type ezrin or T567D ezrin or 1–310 ezrin
as indicated and placed 4 h later on a layer of IL1β-stimulated human
endothelial cells in the absence of added chemokine. Random
migration of the transfected T cells was assessed for 10 min by
time-lapse videomicroscopy at 37˚C. The % of migrating transfected T
cells (A,C) and the mean speed of the migrating transfected T cells
(B,D) was evaluated. Mean±SEM of three experiments. *P <0.05,
**P <0.01 for statistically significant differences between data as
indicated (total number of T cells analyzed in three experiments:
247/656 cells transfected with EGFP; 376/574 cells transfected with
wild type ezrin; 437 cells transfected with T567D ezrin; 679 cells
transfected with 1–310 ezrin). (E) T cells were transfected with the
indicated constructs and placed 4 h later into filter inserts. The lower
and upper wells (open bars) or only the lower wells (closed bars)
contained 200 ng/ml SDF-1. The number of transfected migrated T cells
in the lower wells was determined after 1 h and calculated as % of total
transfected T cells placed initially into the upper wells. In the absence
of SDF-1 in the lower wells migration was zero for all samples and
experiments. Mean±SEM of eight experiments for SDF-1 only in the
lower wells and of three experiments for SDF-1 in the upper and lower
wells. *P <0.05, ***P <0.001 for statistically significant differences
between data as indicated.
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endogenous ERM proteins and uncoupling of actin from the
plasma membrane. In addition, this construct has the poten-
tial to disrupt other processes not directly regulated by ERM
proteins. For example, 1–310 ezrin could interact with PIP-2
and prevent its interaction with other targets. Note that this
construct has significant negative effects on T cell functions
despite its relatively low level of expression (Figure 2). Possi-
bly this can be explained by only a small fraction of the total
ERM protein pool being in the active form in human T cells
(Figure 1), whose function can be inhibited by low levels of 1–310
ezrin.
In conclusion, we show that expression of constitutively active
T567D ezrin in freshly isolated human T cells is sufficient to
induce cell polarization, that is, formation of a contracted uro-
pod enriched in flotillins and PSGL-1, and a front with F-
actin-rich ruffles. These polarized cells show increased random
migration in the absence of added chemokine. Uropod for-
mation, but not ruffling, induced by T567D ezrin is partly
dependent on myosin II/Rho-kinase activity. Conversely, transfec-
tion with dominant-negative 1–310 ezrin attenuates chemokine-
induced polarization, capping of uropod proteins, spontaneous
2D migration, and chemotaxis. Our data indicate an impor-
tant positive role of ERM proteins in polarization and migra-
tion of T cells and suggest that flotillins and ERM proteins
cooperate in uropod formation. Open questions concern the
exact roles of ERM proteins in uropod scaffolding and signaling
and the mechanisms of cooperation between flotillins and ERM
proteins.
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